ClinicalTrials.gov
ClinicalTrials.gov Menu

MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry (MORE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01347944
Recruitment Status : Completed
First Posted : May 5, 2011
Last Update Posted : March 24, 2016
Sponsor:
Information provided by (Responsible Party):
Celgene Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2013
  Actual Study Completion Date : June 2013